Shield Therapeutics plc (STX) — Tangible Net Worth Ratio
Shield Therapeutics plc (STX) has a Tangible Net Worth Ratio of -3116.5% as of June 2024. This metric is calculated by deducting intangible assets (GBX13.77 Million) from net assets (GBX427.97K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Shield Therapeutics plc to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shield Therapeutics plc Tangible Net Worth Ratio (2016–2023)
This chart shows how Shield Therapeutics plc's Tangible Net Worth Ratio has changed across 8 annual periods from 2016 to 2023. As of June 2024, the ratio stands at -3116.5%, reflecting net assets of GBX427.97K with intangible assets of GBX13.77 Million GBX. For live market cap and overall valuation, see STX market cap overview.
Annual Tangible Net Worth Ratio for Shield Therapeutics plc (2016–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Shield Therapeutics plc from 2016 to 2023, covering 8 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Shield Therapeutics plc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 24.4% | GBX22.31 Million | GBX16.86 Million | GBX48.80 Million | ▲ +141.5 pp |
| 2022 | -117.1% | GBX5.43 Million | GBX11.78 Million | GBX22.07 Million | ▼ -151.7 pp |
| 2021 | 34.6% | GBX41.03 Million | GBX26.85 Million | GBX44.41 Million | ▲ +24.6 pp |
| 2020 | 9.9% | GBX30.28 Million | GBX27.27 Million | GBX32.53 Million | ▲ +3.0 pp |
| 2019 | 7.0% | GBX32.15 Million | GBX29.90 Million | GBX36.32 Million | ▼ -16.4 pp |
| 2018 | 23.4% | GBX40.43 Million | GBX30.96 Million | GBX43.38 Million | ▼ -3.9 pp |
| 2017 | 27.3% | GBX41.21 Million | GBX29.96 Million | GBX44.97 Million | ▼ -12.8 pp |
| 2016 | 40.1% | GBX48.40 Million | GBX28.98 Million | GBX52.38 Million | — |